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A B S T R A C T   
Introduction: The assessment and treatment of low relative muscle power in older people has received little 
attention in the clinical setting when compared to sarcopenia. Our main goal was to assess the associations of low 
relative power and sarcopenia with other negative outcomes in older people. 
Methods: The participants were 1189 subjects (54% women; 65–101 years old) from the Toledo Study for Healthy 
Aging. Probable sarcopenia was defined as having low handgrip strength, while confirmed sarcopenia also 
included low appendicular skeletal muscle index (assessed by dual energy X-ray absorptiometry) (EWGSOP2’s 
definition). Low relative (i.e. normalized to body mass) muscle power was assessed with the 5-repetition sit-to- 
stand power test (which uses an equation that converts sit-to-stand performance into mechanical power) and 
diagnosed in those subjects in the lowest sex-specific tertile. Low usual gait speed (UGS), frailty (according to 
Fried’s criteria and the Frailty Trait Scale), limitations in basic (BADL) and instrumental activities of daily living 
(IADL) and poor quality of life were also recorded. 
Results: Age-adjusted logistic regression analyses demonstrated that low relative muscle power was associated 
with low UGS (odds ratio (OR) = 1.9 and 2.5), frailty (OR = 3.9 and 4.7) and poor quality of life (OR = 1.8 and 
1.9) in older men and women, respectively, and with limitations in BADL (OR = 1.6) and IADL (OR = 3.8) in 
older women (all p < 0.05). Confirmed sarcopenia was only associated with low UGS (OR = 2.5) and frailty (OR 
= 5.0) in older men, and with limitations in IADL in older women (OR = 4.3) (all p < 0.05). 
Conclusions: Low relative muscle power had a greater clinical relevance than low handgrip strength and 
confirmed sarcopenia among older people. An operational definition and algorithm for low relative muscle 
power case finding in daily clinical practice was presented.   
1. Introduction 
The deterioration of functional capacity is one of the main hallmarks 
and negative consequences of aging. Notably, presenting functional 
limitations increases costs associated with falls and hospitalization, and 
mortality risk to a greater extent than multimorbidity (Grundstrom 
et al., 2012; Kumar et al., 2017; Landi et al., 2010). Thus, building and 
maintaining functional ability and intrinsic capacity are key healthy 
aging goals that must be adopted by health systems (Steves et al., 2012; 
Thiyagarajan et al., 2019; World Health Organization, 2015). 
Sarcopenia has progressively received increased attention due to its 
association with increased risk of disability and mobility limitations 
(Baumgartner et al., 1998; Janssen et al., 2002) and their associated 
heath care costs (Pinedo-Villanueva et al., 2019). Sarcopenia is defined 
as the age-related loss of muscle mass and strength and its assessment is 
strongly encouraged in the clinical setting (Cruz-Jentoft et al., 2019). 
Abbreviations: ASMI, appendicular skeletal muscle index; BADL, basic activities of daily living; BMI, body mass index; DXA, dual energy X-ray absorptiometry; 
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However, there are other components of the neuromuscular system that 
may be more relevant for the older adults’ functional ability. Mechanical 
power (or muscle power in humans) declines with age at a higher rate 
than muscle mass and strength, and has also shown a higher association 
with functional limitations and mortality than sarcopenia (Akima et al., 
2001; Doherty, 2003; Lauretani et al., 2003; Pearson et al., 2002; Reid 
et al., 2014; Siglinsky et al., 2015; Skelton et al., 1994). Early reports 
demonstrated the major relevance of muscle power in older people 
(Bassey et al., 1992; Skelton et al., 1994), but its assessment and utili-
zation has not been adequately encouraged and addressed in the clinical 
setting. This contrasts with the progressively increased attention that the 
definition and evaluation of sarcopenia has received during the last 
decade. One reason for this might be that the traditional instruments and 
procedures employed to measure muscle power may inherently present 
several technical and economic barriers that may restrain their use in the 
clinical setting and in large cohort studies (Alcazar et al., 2017). In this 
sense, a recent position paper pointed out that the assessment of muscle 
power cannot be indicated in the clinical setting due to the lack of 
feasible and standardized protocols (Beaudart et al., 2019). 
Interestingly, as recently reported, the assessment of muscle power 
may be feasible in the clinical setting by means of the sit-to-stand (STS) 
muscle power test (Alcazar et al., 2020b; Alcazar et al., 2018a). This 
procedure uses a validated equation that converts STS performance into 
muscle power and only requires a stopwatch and a chair. Notably, STS 
muscle power showed a larger association with physical and cognitive 
function than STS performance and handgrip strength among older 
people (Alcazar et al., 2020b; Alcazar et al., 2018a). However, the use of 
the STS muscle power test has not been compared to the assessment of 
sarcopenia in terms of their associations with other negative outcomes in 
older men and older women. Finally, it must be considered that the 
normalization of muscle power to body mass (i.e. relative muscle power) 
strengthens the relationship of muscle power with physical performance 
(Alcazar et al., 2018a; Alcazar et al., 2018b; Skelton et al., 1994). Thus, 
the main goals of the present study were to provide an operational 
definition and algorithm of low relative muscle power in older people 
and to assess the ability of sarcopenia and low relative muscle power 
(evaluated by the STS muscle power test) to associate with impaired gait 
speed, frailty, disability and poor quality of life. Our hypothesis was that 
the provided operational definition of low relative muscle power will be 
more strongly related with the above-mentioned negative outcomes 
than sarcopenia. In addition, relative muscle power has previously been 
observed to decline after the fourth decade of life due to age- and sex- 
specific changes in its contributing factors: allometric power, body 
mass index, specific power and legs skeletal muscle index (Alcazar et al., 
2020). Thus, a second goal of the present investigation was to assess the 
impact that the different components accounting for relative muscle 
power have in physical function and frailty. 
2. Methods 
2.1. Participants 
The Toledo Study for Healthy Aging (TSHA) is a prospective cohort 
study involving men and women over 65 years of age (Garcia-Garcia 
et al., 2011). Older subjects participating in the TSHA were selected by a 
two-stage random sampling of the municipal census of the province of 
Toledo (Spain) (Garcia-Garcia et al., 2011). In total, 1189 older adults 
(53.7% women) completed all the required examinations and partici-
pated in the current investigation (Table 1). The main characteristics of 
the participants were assessed by the Mini-mental State Examination 
questionnaire (cognitive function) (Folstein et al., 1975) and the Short 
Physical Performance Battery (physical performance) (Guralnik et al., 
1994). All the study participants signed a written informed consent, and 
the study protocol was approved by the Clinical Research Ethics Com-
mittee of the Complejo Hospitalario de Toledo (Spain). 
2.2. Anthropometrics 
Height and body mass were assessed, respectively, with a portable 
stadiometer (Medizintechnikseit 1890, KaWe, Germany) and a precision 
scale (SECA 884 floor scale, Germany). Participants removed shoes, 
socks and heavy clothes prior to these assessments. Body mass index 
(BMI) was calculated as the ratio between body mass and height2 
(kg⋅m− 2). 
2.3. Sarcopenia 
Sarcopenia was defined according to the last report provided by the 
European Working Group on Sarcopenia in Older People (EWGSOP) 
(Cruz-Jentoft et al., 2019). Lean mass was assessed by dual energy X-ray 
absorptiometry (DXA) (Hologic, Serie Discovery QDR, Bedford, USA). 
DXA scans were analyzed using commercially available software (Phy-
sician’s Viewer, APEX System Software Version 3.1.2, Bedford, USA) 
and appendicular lean mass was obtained. Then, appendicular skeletal 
muscle index (ASMI) was calculated as the ratio between appendicular 
lean mass and height2 (kg⋅m− 2). In addition, a hand held dynamometer 
(Jamar Preston, Jackson, MI, USA) was utilized to measure handgrip 
strength. As previously reported, cut-off points for low ASMI were <7.0 
kg⋅m− 2 for men and <5.5 kg⋅m− 2 for women, while cut-off points for low 
handgrip strength were <27 kg for men and <16 kg for women (Cruz- 
Jentoft et al., 2019). Finally, probable sarcopenia was defined as having 
low handgrip strength and confirmed sarcopenia was defined as having 
both low handgrip strength and low ASMI. 
2.4. Relative muscle power 
The STS muscle power test was used to assess mechanical power 
(Alcazar et al., 2018a). Participants were instructed to perform 5 timed 
STS repetitions after the cue “ready, set, go!”, as fast as possible, on a 
standardized armless chair (height = 0.43 m) with arms crossed over the 
chest. Importantly, from the sitting position, they had to fully extend 
their knees and hips to the standing position, and descend to the sitting 
position until at least touching the chair with their buttocks. The test was 
repeated when any of these instructions was broken. The time (±0.01 s) 
needed to perform 5 STS repetitions was recorded using a stopwatch. 
Absolute STS muscle power (W) was calculated using the following 
equation (Alcazar et al., 2018a): 
STSpower (W)=
Body mass×0.9×9.81×[Body height×0.5 − Chair height ]
FiveSTStime×0.1  
where body mass is indicated in kg, body height and chair height in m, 
and five STS time in s. This equation is based on several biomechanical 
principles that have been clarified elsewhere (Alcazar et al., 2018a). 
Briefly, 0.9 is a coefficient applied to body mass to calculate the body 
mass that is displaced during the STS task (whole body mass minus 
shank and feet mass), 0.5 is a coefficient applied to body height to 
Table 1 
Main characteristics of the study participants.   
Men (n = 550) Women (n = 639) p value All (n = 1189) 
Age (years) 75.7 ± 5.9 76.0 ± 5.9  0.381 75.8 ± 5.9 
Body mass (kg) 76.5 ± 11.9 68.9 ± 12.0  <0.001 72.4 ± 12.5 
Height (m) 1.64 ± 0.07 1.50 ± 0.06  <0.001 1.56 ± 0.09 
BMI (kg⋅m− 2) 28.5 ± 3.9 30.5 ± 5.1  <0.001 29.6 ± 4.7 
MMSE score 24.9 ± 4.0 23.9 ± 4.2  <0.001 24.4 ± 4.1 
SPPB score 9.3 ± 2.0 8.3 ± 2.3  <0.001 8.8 ± 2.2 
Katz index 5.9 ± 0.3 5.8 ± 0.4  <0.001 5.9 ± 0.4 
Lawton index 6.6 ± 1.6 7.5 ± 1.2  <0.001 7.1 ± 1.5 
Note: BMI, body mass index. MMSE, mini-mental state examination. SPPB, short 
physical performance battery. p values denote significant differences between 
men and women according to unpaired t-tests. 
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calculate leg length, and 0.1 is a coefficient applied to total 5-rep STS 
time to calculate the average duration of the concentric phase of 1 STS 
repetition. Then, absolute STS power was normalized to body mass to 
calculate relative STS power (W⋅kg− 1), which denotes the ability to 
produce mechanical power per unit of body mass. Allometric STS power 
(W⋅m− 2), a scaled measure of mechanical power, was obtained by 
normalizing absolute STS power to height2. Finally, specific STS power 
(W⋅kg− 1) was obtained from the ratio between absolute STS power and 
legs lean mass, and indicates the ability to exert lower-limb mechanical 
power per unit of lower-limb muscle mass. Legs lean mass was derived 
from regional analyses conducted on whole body DXA scans. Please note 
that allometric muscle power can also be obtained from the product of 
relative muscle power and BMI, while specific muscle power can also be 
obtained from the ratio between allometric muscle power and legs 
skeletal muscle index (SMI; ratio between legs lean mass and height2). 
Therefore, these components must be part of the operational algorithm 
to detect low relative muscle power and their causes. Sex-specific tertiles 
were used to determine low, medium and high levels of relative STS 
power and its main components (Fig. 1). 
2.5. Usual gait speed 
Usual gait speed (UGS) was assessed over a 3-m distance. The sub-
jects were asked to walk at their habitual velocity and instructed to 
continue beyond the 3-m distance to avoid everyone from stopping or 
slowing down before reaching the 3-m distance. A stopwatch was used 
to measure the time (s) needed to complete the task, and velocity (m⋅s− 1) 
was calculated. Low UGS was defined as the lowest sex-specific tertile in 
our sample (<0.68 m⋅s− 1 for men and < 0.55 m⋅s− 1 for women). 
2.6. Frailty 
Two different scales were used to assess frailty: the Fried’s frailty 
syndrome (Fried et al., 2001) and the Frailty Trait Scale (FTS) (García- 
García et al., 2014). Frailty syndrome was assessed using the procedures 
presented in the original study (Fried et al., 2001), so it was defined as 
presenting at least 3 of the following frailty criteria: unintentional 
weight loss (>4.5 kg in prior year), weakness (sex- and BMI-specific low 
handgrip strength), slowness (sex- and height-specific low usual gait 
speed), fatigue (self-reported exhaustion) and physical inactivity (self- 
reported walking time <2.5 h⋅week− 1 in men and <2.0 h⋅week− 1 in 
women). The FTS evaluates 7 different dimensions (nutrition, balance of 
energy, nervous system, physical activity, vascular system, endurance, 
strength, and gait speed) that in turn are recorded throughout 12 items 
(García-García et al., 2014). Each of the FTS items scores from 0 to 4 
points, with a higher score indicating a higher level of frailty. The items 
include, among other tests, the assessment of serum albumin levels, 
verbal fluency, brachial-ankle index (Doppler ultrasonography) and 
knee extension strength (Lafayette dynamometer). The FTS items are 
described in further detail in the original publication (García-García 
et al., 2014). FTS’s frailty was defined as scoring ≥50 points (García- 
García et al., 2014). 
Fig. 1. Hierarchical classification of variables accounting for relative muscle power. Relative muscle power is dependent of allometric muscle power and body mass 
index. In turn, allometric muscle power is dependent of specific muscle power and legs skeletal muscle index. Low, medium and high levels of each component were 
calculated based on sex-specific tertiles. 
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2.7. Disability 
Disability in basic and instrumental activities of daily living (BADL 
and IADL) was assessed by the Katz index (Katz et al., 1970) and the 
Lawton and Brody Scale (Lawton and Brody, 1969), respectively. In 
these questionnaires, limitations in BADL (bathing, continence, feeding, 
toilet use, dressing, and chair/bed transfer) and IADL (cooking, doing 
laundry, handling medications, using the telephone, housekeeping, 
shopping, use of transportation, and handling finances) are self-reported 
by the participants. 
2.8. Health-related quality of life 
Health-related quality of life was assessed by the EQ-5D-5L ques-
tionnaire (Herdman et al., 2011). This questionnaire registers the par-
ticipants’ self-reported information on 5 different dimensions (mobility, 
pain/discomfort, self-care, anxiety/depression, and usual activities) and 
health status (Herdman et al., 2011). Poor quality of life was declared in 
those older adults in the lowest sex-specific tertiles of both EQ-index 
(<1.00 for men and <0.91 for women) and EQ-visual analogue scale 
(<70 for men and <50 for women). 
2.9. Statistical analysis 
Continuous variables were presented as mean ± standard deviation 
unless otherwise stated. Normality of distribution was confirmed for 
continuous variables by Shapiro-Wilk’s tests. All analyses were per-
formed in women and men separately due to the sex-related differences 
that have been previously reported regarding the effects of aging on 
anthropometrics, body composition and muscle function (Alcazar et al., 
2020). Logistic regression analyses (odds ratio (OR) [95% confidence 
intervals (CI)]) adjusted for age were used to assess the associations of 
sarcopenia and low relative STS power with low UGS, frailty, limitations 
in BADL and IADL, and poor quality of life. To check the influence of the 
variables accounting for relative muscle power, differences in UGS and 
FTS-based frailty among groups of older people presenting various 
combinations of 1) allometric STS muscle power and BMI and 2) specific 
STS muscle power and legs SMI were assessed by one-way ANOVA. 
Pairwise comparisons (vs. reference group) were carried out using 
Bonferroni’s tests in case of homogeneity of variances, and Games- 
Howell’s tests in case of heterogeneity of variances. The reference group 
was declared to be the group with higher values of relative muscle power 
and allometric muscle power, respectively: 1) combination of high 
allometric STS power and low BMI; and 2) combination of high specific 
STS power and high legs SMI. Finally, to extend the applicability of our 
proposed algorithm to those contexts in which body composition anal-
ysis and legs SMI determination are limited, optimal cut-off points for 
the recognition of older adults with low legs SMI were assessed by 
receiver operator characteristic (ROC) curves. Cur-off values of BMI 
were selected for older men and older women based on the best trade-off 
between sensitivity and specificity according to the highest product of 
both. All analyses were carried out with SPSS v22 (SPSS Inc., Chicago, 
Illinois). The level of significance was set at α = 0.05. 
3. Results 
3.1. Impact of sarcopenia and low relative muscle power on usual gait 
speed, frailty, disability and quality of life 
The age-adjusted associations of probable (low handgrip strength) 
and confirmed (low handgrip strength plus low ASMI) sarcopenia and 
low relative muscle power with low UGS, frailty, disability and quality 
of are shown in Table 2. 
Among men, either probable or confirmed sarcopenia augmented the 
ORs for low UGS and Fried’s frailty, while only probable sarcopenia 
augmented the OR for FTS-based frailty. Confirmed sarcopenia had no 
impact on FTS-based frailty, limitations in BADL or IADL and quality of 
life. On the other hand, men experiencing low relative STS muscle power 
had increased ORs for low UGS, Fried’s and FTS-based frailty, and poor 
quality of life, while no effect on limitations in BADL or IADL was noted. 
Among women, probable sarcopenia increased the odds for FTS- 
based frailty and confirmed sarcopenia increased the odds for having 
limitations in IADL, but no significant effects were found for any of the 
other variables. On the other hand, women with a low relative STS 
power presented increased ORs for low UGS, FTS-based frailty, limita-
tions in BADL and IADL and poor quality of life. However, low relative 
STS power was not associated with Fried’s frailty in women. 
3.2. Impact of various combinations of allometric muscle power and body 
mass index on usual gait speed and frailty 
In men, the groups with medium or low allometric STS power dis-
played lower UGS (all p ≤ 0.002 and p < 0.001, respectively) and higher 
FTS-based frailty values (all p < 0.001) when compared to the reference 
group independently of BMI levels (Fig. 2A and B). In addition, frailty 
was higher in the groups with high allometric STS power combined with 
medium or high BMI (both p < 0.001). 
In women, lower UGS values were noted in the groups exhibiting low 
Table 2 
Logistic regression analysis comparing the associations of sarcopenia and low relative sit-to-stand power with other negative outcomes.   
Probable sarcopenia (low handgrip strength) Confirmed sarcopenia (both low handgrip strength and low ASMI) Low relative STS power 
OR (95% CI)a p OR (95% CI)a p OR (95% CI)a p 
Men 
Low UGS  2.1 (1.3–3.3)  0.002  2.5 (1.2–4.9)  0.010  1.9 (1.2–3.0)  0.006 
Frailty (Fried)  18.4 (2.2–155.3)  0.007  5.0 (1.2–20.0)  0.023  4.5 (1.1–18.0)  0.036 
Frailty (FTS)  3.5 (2.1–5.9)  <0.001  1.7 (0.8–3.7)  0.157  3.9 (2.4–6.3)  <0.001 
≥1 limitation in BADL  1.6 (0.8–2.9)  0.159  2.2 (1.0–4.9)  0.064  1.5 (0.8–2.8)  0.157 
≥1 limitation in IADL  1.4 (0.9–2.0)  0.140  1.2 (0.6–2.5)  0.526  1.2 (0.8–1.7)  0.433 
Poor quality of life  1.0 (0.6–1.7)  0.927  0.9 (0.4–2.1)  0.874  1.8 (1.1–2.8)  0.016  
Women 
Low UGS  1.4 (0.9–2.2)  0.179  2.2 (0.9–5.6)  0.084  2.5 (1.6–3.9)  <0.001 
Frailty (Fried)  5.0 (0.9–29.2)  0.072  6.7 (1.0–42.4)  0.055  4.2 (0.8–24.2)  0.110 
Frailty (FTS)  3.2 (2.2–4.7)  <0.001  0.6 (0.2–1.5)  0.260  4.7 (3.2–6.9)  <0.001 
≥1 limitation in BADL  1.4 (0.9–2.2)  0.140  2.4 (1.0–5.7)  0.052  1.6 (1.1–2.5)  0.026 
≥1 limitation in IADL  1.5 (1.0–2.4)  0.052  4.3 (1.6–11.4)  0.003  3.8 (2.5–5.7)  <0.001 
Poor quality of life  1.3 (0.9–1.8)  0.204  1.1 (0.5–2.6)  0.797  1.9 (1.3–2.6)  0.001 
Note: ASMI, appendicular skeletal muscle index. OR, odds ratio. CI, confidence interval. BADL, basic activities of daily living. UGS, usual gait speed. IADL, instrumental 
activities of daily living. Bold values and * indicate p < 0.05. 
a All the analyses were adjusted by age. 
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allometric STS power regardless of BMI (all p < 0.001), and also in the 
group showing a medium allometric STS power in combination with a 
high BMI (p < 0.001) (Fig. 2A). Moreover, FTS-based frailty was higher 
in women presenting low allometric STS power independently of BMI 
levels (all p < 0.001), in women with medium allometric STS power in 
combination with medium or high BMI (both p < 0.001), and in women 
exhibiting high allometric STS power plus either medium or high BMI (p 
= 0.017 and p < 0.001, respectively) (Fig. 2B). 
The percentages of older men and older women experiencing low 
UGS and frailty are presented in detail at the bottom of Fig. 2. 
3.3. Impact of various combinations of specific muscle power and legs 
skeletal muscle index on usual gait speed and frailty 
Men with low specific STS power presented lower values of UGS 
independently of legs SMI levels (all p ≤ 0.02). Moreover, men with 
medium specific STS power combined with either medium or low legs 
SMI also presented lower UGS levels than the reference group (p = 0.022 
and p = 0.002, respectively) (Fig. 3A). Regarding frailty, the male group 
with high specific STS power and low legs SMI displayed decreased FTS 
values (p = 0.049), while higher FTS values were noted in the male 
group with low specific STS power and either high or low legs SMI 
Fig. 2. Comparison of usual gait speed (UGS) (A) and frailty (B) levels among various groups of older men (black bars) and women (grey bars) combining different 
levels of allometric sit-to-stand (STS) power and body mass index (BMI). Percentages (%) of older people with low UGS (A) and frailty (B) are shown below the bars. 
Significant differences compared with the reference group are denoted by * in men and ¥ in women (p < 0.05). The reference group is H-L (i.e. high allometric STS 
power and low BMI). Note: H, high. M, medium. L, low. 
Fig. 3. Comparison of usual gait speed (UGS) (A) and frailty (B) levels among various groups of older men (black bars) and women (grey bars) combining different 
levels of specific STS power and legs skeletal muscle index (SMI). Percentages (%) of older people with low UGS (A) and frailty (B) are shown below the bars. 
Significant differences compared with the reference group are denoted by * in men and ¥ in women (p < 0.05). The reference group is H-H (i.e. high specific STS 
power and high legs SMI). Note: H, high. M, medium. L, low. 
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(Fig. 3B) (p = 0.002 and p = 0.044, respectively). 
In women, UGS was lower in the group exhibiting low specific STS 
power independently of legs SMI (all p < 0.001) (Fig. 3A). Regarding 
frailty, lower FTS values were noted in women presenting high specific 
STS power combined with low legs SMI (p < 0.001), but frailty 
augmented in the female group with low specific STS power combined 
with either high or medium legs SMI (p < 0.001 and p = 0.002, 
respectively) (Fig. 3B). 
Further details on the percentages of older men and older women 
with low UGS and frailty can be observed at the bottom of Fig. 3. 
3.4. Operational algorithm for low relative muscle power detection 
An operational algorithm for the detection of low relative muscle 
power and the underlying factors that contribute to low relative muscle 
power is presented in Fig. 4. Cut-off points of BMI below which low legs 
SMI is probable were 27.9 kg⋅m− 2 in men (AUC [95% CI] = 0.87 
[0.81–0.93], sensitivity = 83%, specificity = 80%) and 28.5 kg⋅m− 2 in 
women (AUC [95% CI] = 0.88 [0.82–0.94], sensitivity = 81%, speci-
ficity = 81%). 
4. Discussion 
The main findings of the present investigation were: i) low relative 
muscle power evaluated with the STS muscle power test increased the 
odds for having low gait speed, frailty and poor quality of life in older 
men and women, and the odds for having limitations in BADL and IADL 
in older women alone; ii) probable sarcopenia (low handgrip strength) 
only augmented the odds for having frailty in older men and women, 
and the odds for having low gait speed in men alone; iii) confirmed 
sarcopenia (low handgrip strength plus low ASMI) only increased the 
odds for having low gait speed and frailty in older men, and the odds for 
having limitations in IADL in older women; and iv) the negative con-
sequences of low relative muscle power were modulated by the different 
combinations of allometric muscle power and BMI, and specific muscle 
power and legs SMI. 
Although the relevance of the assessment of sarcopenia in the man-
agement of functional trajectories with aging must be acknowledged 
(Cruz-Jentoft and Sayer, 2019), muscle power has been reported to be of 
higher relevance for older people’s functional ability (Foldvari et al., 
2000; Martinikorena et al., 2016; Metter et al., 2004). The superiority of 
low relative muscle power over sarcopenia in terms of being associated 
with physical performance, frailty, disability and poor quality of life 
among older men and women may be due to the fact that muscle power 
reflects the ability of the motor system to perform mechanical work per 
unit of time, while other factors such as muscle mass or strength are 
partial contributors to this ability. However, interestingly low relative 
muscle power was associated with disability in activities of daily living 
among older women, but not in older men. Other study in the past re-
ported similar findings regarding the sex-specific association of low 
muscle function with disability in activities of daily living (Kozicka and 
Kostka, 2016). Perhaps this fact is related to the unbalance that 
Fig. 4. Algorithm to detect low relative muscle power and their causes. Older adults presenting low relative muscle power should participate in a supervised 
intervention designed to improve the physiological components accounting for low relative muscle power. Part A of the algorithm can be accomplished without body 
composition examination. In addition, in those older subjects with low allometric muscle power and low BMI (according to the provided cut-off values), body 
composition examination (DXA or other validated instrument) should be performed when available in order to determine the specific causes leading to low allometric 
power. Note: STS, sit-to stand. BMI, body mass index. SMI, skeletal muscle index. 
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traditionally exists between women and men with respect to participa-
tion in household activities (Cerrato and Cifre, 2018). In order to 
overcome the traditional methodological issues related to muscle power 
assessment (Beaudart et al., 2019), the STS muscle power test may 
provide an opportunity to assess muscle power in older people in a 
feasible, valid and inexpensive way, given that only a chair and a 
stopwatch are required (Alcazar et al., 2018a). Of note, the traditional 
repetition- or time-based STS performance measures that are sometimes 
recommended as a measure of lower-body strength or power are indeed 
measures of physical performance. The interpretation of STS perfor-
mance as a measure of muscle strength or power should be strongly 
discouraged simply because STS performance is not expressed in any 
strength- or power-related unit (i.e. N or W). The STS muscle power test 
provides an equation that allows the calculation of legs extensor power 
from traditional STS data. The STS power test was effectively reported to 
improve the ability of traditional STS measures to predict physical and 
cognitive function in older adults (Alcazar et al., 2018a). In addition, as 
confirmed in the current study, the STS muscle power test was more 
strongly related to functional performance in older adults than other 
frequently used measures, such as handgrip strength or muscle power 
assessed with the Nottingham power rig (Alcazar et al., 2020b). 
Therefore, this procedure may be truly adequate and feasible in daily 
clinical practice as well in large cohort studies (Alcazar et al., 2018a). 
Accordingly, a flowchart to guide health professionals in evaluating 
low relative muscle power and determining its causes in their daily 
practice is proposed in Fig. 4. First, older subjects with low relative 
muscle power should be identified after conducting the STS muscle 
power test. In those older adults with low relative muscle power, part A 
of the proposed algorithm helps to determine whether it is related to low 
allometric STS power, high BMI, or both. Importantly, DXA scanning is 
not required in part A. Then, specific interventions aimed to improve 
allometric STS power, decrease BMI or both, can be appropriately pre-
scribed. In addition, in case of low allometric STS power, whether it is 
related to low specific STS power, low legs SMI, or both, can be eluci-
dated in part B of the proposed algorithm, which requires of body 
composition analysis. However, when the costs associated with legs 
muscle mass determination prevent its application, leg muscle mass 
might be only recommended in older subjects at risk for low leg SMI 
according to BMI values (men: BMI <27.9 kg⋅m− 2; and women: BMI 
<28.5 kg⋅m− 2). 
The presented approach has various advantages when compared to 
the current sarcopenia definition (Cruz-Jentoft et al., 2019). First, the 
mechanisms accounting for low relative muscle power can be identified 
and accordingly treated. It is noteworthy that the mechanisms contrib-
uting to the loss of relative muscle power with age differ among various 
stages in life (Alcazar et al., 2020). Throughout the fifth and sixth de-
cades of life (40–60 years old) it seems to be related to the loss of specific 
muscle power and the increase in BMI, while it is related to the loss of 
specific muscle power and leg SMI approximately during the seventh 
and eighth decades of life in men and women, respectively (Alcazar 
et al., 2020). Thus, older people with low relative power may require 
different strategies addressing their specific needs, and this can be 
accomplished with the help of the proposed algorithm. Second, unlike 
for sarcopenia diagnosis (Cruz-Jentoft et al., 2019), body composition 
analysis is not imperative to determine low relative muscle power, 
which may potentially augments its utilization in the clinical setting. In 
any case, when body composition analysis is available, we provided sex- 
specific cut-off points to better identify older people with low allometric 
STS power requiring body composition analysis to discern whether or 
not it may be related to low legs SMI. This filtering procedure reduces 
the proportion of older people requiring body composition analysis 
(11% of older men and 10% of older women) and its associated costs 
when compared with the percentage of older men and women that 
would require body composition analysis according to the current sar-
copenia definition (i.e. older people from the present study with hand-
grip strength below the cut-off points proposed by the EWGSOP (Cruz- 
Jentoft et al., 2019): 25% of older men and 27% of older women). 
Most importantly, once all the deficits related with low relative 
muscle power are identified, these can be treated according to the 
existing evidence in order to revert this negative condition. For instance, 
a low relative muscle power related to an excessive BMI can be treated 
with interventions combining adequate nutrition and exercise training 
that achieve an appropriate negative energy balance (Villareal et al., 
2011). In older adults with low allometric STS power and low specific 
STS power a power-oriented resistance training program should be 
prescribed (Byrne et al., 2016; Losa-Reyna et al., 2019). Finally, in-
terventions aiming to increase low legs SMI should include adequate 
nutrient intake (overall including essential amino acid and β-hydroxy 
β-methylbutyric acid supplementation, and at least 1.2 g of protein per 
kg of body mass) and resistance training (Bauer et al., 2013; Cruz-Jentoft 
et al., 2014). 
Definitely, it must be clarified that the differences in gait speed and 
frailty observed among the different groups of allometric power and 
BMI, and specific power and legs SMI were due to the underlying dif-
ferences in relative muscle power among groups. Obviously, having a 
greater allometric power combined with a lower BMI leads to a greater 
relative muscle power, which is positively associated with gait speed 
and negatively associated with frailty. Furthermore, having greater 
specific power and legs SMI leads to greater allometric power, which in 
turn should lead to greater relative power. Nevertheless, greater levels of 
frailty were surprisingly associated with high legs SMI. This fact may be 
related to older people with high legs SMI having greater BMI as well, 
leading to less relative muscle power. Indeed, when we conducted a 
secondary analysis considering normal-weight and obese subjects (i.e. 
below and above 30 kg⋅m− 2, respectively), there was no relation be-
tween legs SMI and frailty. These findings point out that clinical care 
models for older people require consideration of muscle function, 
muscle mass and BMI. All these components are regarded within the 
algorithm proposed in the present study. It should be noted that the 
application of more clinically relevant tools related with older people’s 
functional ability is supported by the recently encouraged necessity of 
redesigning care for older people to preserve physical and cognitive 
performance (Thiyagarajan et al., 2019). Several studies have shown 
that exercise interventions provide substantial and clinical benefits to 
either healthy, chronically or acutely ill older people (Cadore et al., 
2014; García-Hermoso et al., 2020; Martínez-Velilla et al., 2019; Sáez de 
Asteasu et al., 2019). In this scenario, our proposed algorithm may help 
improve the identification of patients needing an exercise intervention 
and optimize exercise dosing. 
There are several limitations that should be acknowledged. This is a 
cross-sectional study, and thus we cannot establish cause-effect re-
lationships. However, low muscle power has already demonstrated its 
prognostic value in terms of cognitive decline (Steves et al., 2016), 
incident disability (Hicks et al., 2012) and mortality (Metter et al., 
2004). Moreover, low relative muscle power was established according 
to sex-specific tertiles in the present study. Thus, further studies should 
be conducted to find optimal cut-off points based on their ability to 
detect older adults at an increased risk for frailty and disability. 
5. Conclusions 
Low relative STS muscle power showed a greater clinical relevance 
than probable (low handgrip strength) and confirmed (low handgrip 
strength plus low ASMI) sarcopenia among older men and women. 
Specifically, low relative STS muscle power was significantly associated 
with low UGS, frailty and poor quality of life in both older men and 
women, and with limitations in BADL and IADL in older women; while 
confirmed sarcopenia was only associated with low UGS and frailty 
among older men, and with limitations in IADL among older women. 
The STS muscle power test and the proposed algorithm provides health 
professionals the opportunity to assess and diagnose low relative muscle 
power in their daily practice. Additionally, the main determinants of low 
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relative muscle power can be identified and specific interventions can be 
prescribed to revert this negative condition. 
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